Stonebridge Capital Advisors LLC Has $24.80 Million Holdings in Oracle Co. (NYSE:ORCL)

Stonebridge Capital Advisors LLC trimmed its stake in Oracle Co. (NYSE:ORCL - Free Report) by 3.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 148,791 shares of the enterprise software provider's stock after selling 4,604 shares during the period. Oracle comprises about 2.0% of Stonebridge Capital Advisors LLC's investment portfolio, making the stock its 12th biggest position. Stonebridge Capital Advisors LLC's holdings in Oracle were worth $24,795,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also made changes to their positions in ORCL. Howard Capital Management Group LLC lifted its holdings in shares of Oracle by 12.4% during the 3rd quarter. Howard Capital Management Group LLC now owns 8,019 shares of the enterprise software provider's stock worth $1,366,000 after acquiring an additional 883 shares during the period. Principal Financial Group Inc. raised its holdings in shares of Oracle by 5.3% in the 3rd quarter. Principal Financial Group Inc. now owns 2,416,362 shares of the enterprise software provider's stock worth $411,748,000 after buying an additional 121,874 shares in the last quarter. Morse Asset Management Inc acquired a new stake in Oracle in the 3rd quarter valued at $2,590,000. Westside Investment Management Inc. grew its holdings in shares of Oracle by 0.6% in the 3rd quarter. Westside Investment Management Inc. now owns 14,961 shares of the enterprise software provider's stock worth $2,499,000 after purchasing an additional 86 shares during the last quarter. Finally, Tudor Financial Inc. bought a new stake in Oracle during the third quarter worth about $1,531,000. Institutional investors and hedge funds own 42.44% of the company's stock.

Insider Transactions at Oracle

In other news, Director Leon E. Panetta sold 5,000 shares of Oracle stock in a transaction dated Friday, April 11th. The shares were sold at an average price of $129.77, for a total value of $648,850.00. Following the completion of the transaction, the director now owns 58,090 shares of the company's stock, valued at $7,538,339.30. This trade represents a 7.93 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Naomi O. Seligman sold 2,000 shares of the company's stock in a transaction dated Wednesday, April 2nd. The shares were sold at an average price of $145.81, for a total transaction of $291,620.00. Following the completion of the sale, the director now directly owns 34,630 shares in the company, valued at approximately $5,049,400.30. The trade was a 5.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 352,174 shares of company stock worth $64,990,957 in the last three months. Insiders own 42.20% of the company's stock.

Wall Street Analysts Forecast Growth

ORCL has been the topic of several research reports. UBS Group reiterated a "market perform" rating on shares of Oracle in a research report on Tuesday, March 11th. DA Davidson decreased their price target on shares of Oracle from $150.00 to $140.00 and set a "neutral" rating on the stock in a research note on Monday, April 14th. Cantor Fitzgerald decreased their price objective on Oracle from $214.00 to $175.00 and set an "overweight" rating on the stock in a research report on Tuesday, March 11th. Westpark Capital began coverage on Oracle in a research report on Tuesday, April 1st. They set a "buy" rating and a $195.00 target price for the company. Finally, Mizuho decreased their price target on Oracle from $210.00 to $180.00 and set an "outperform" rating on the stock in a report on Tuesday, April 15th. Fourteen investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Oracle has an average rating of "Moderate Buy" and a consensus target price of $174.42.

Oracle Stock Performance

Shares of Oracle stock opened at $131.43 on Thursday. The company has a debt-to-equity ratio of 5.65, a current ratio of 0.81 and a quick ratio of 0.81. The firm has a market cap of $367.60 billion, a price-to-earnings ratio of 32.13, a price-to-earnings-growth ratio of 3.46 and a beta of 1.22. Oracle Co. has a one year low of $112.78 and a one year high of $198.31. The stock's 50-day moving average is $148.08 and its 200-day moving average is $165.49.

Oracle (NYSE:ORCL - Get Free Report) last released its quarterly earnings results on Monday, March 10th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts' consensus estimates of $1.49 by ($0.02). Oracle had a return on equity of 133.25% and a net margin of 21.16%. The firm had revenue of $14.13 billion for the quarter, compared to analyst estimates of $14.40 billion. During the same period last year, the company earned $1.41 EPS. The company's revenue was up 6.4% compared to the same quarter last year. Equities analysts predict that Oracle Co. will post 5 earnings per share for the current fiscal year.

Oracle Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, April 23rd. Shareholders of record on Thursday, April 10th were given a dividend of $0.50 per share. The ex-dividend date was Thursday, April 10th. This is a boost from Oracle's previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a yield of 1.52%. Oracle's payout ratio is 46.95%.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Co. (NYSE:ORCL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.